Unimarck believes that Research & Development is the growth engine for its foray into the regulated and semi regulated markets. All R&D initiatives are guided by the organizational philosophy of providing affordable yet high quality medicines for health care and wellness.

Unimarck has state – of - art R&D Centre at Haridwar, managed by the dedicated staff, who work round the clock on Active Pharmaceutical ingredients (APIs), Oral Solid Dosage forms, Injectable etc.

The fully integrated R&D is enabled by QC, QA, teams and WHO-GMP inspected plant.

All developmental activities are conducted as per global regulatory guidelines through in-house quality controlled designs concepts. The Intellectual Property Portfolios are being created for differentiated & innovative ideas.

It has a state-of-the-art facility which spreads over 2000 sq ft.

Overview

Formulation development is the core art and science of preparation of the dosage form. All pharmaceutical products are formulated to specific dosage forms for drugs to be effectively delivered to patients. Typical pharmaceutical dosage forms include parenteral and nonparenteral dosage forms. A variety of dosage forms require separate pharmaceutical technologies to be adopted and usually present different technical challenges for formulation development.

Area of interest

Novel Drug Delivery systems
Nanoparticles (Polymeric, solid lipid, liposomes)
Micelles
Polymer-drug conjugates
Targeting (Targeted drug delivery systems)